Clinical and Outcomes Research
Selected Publications from 2008 - 2009
Kim M, Boone SL,West DP, Rademaker AW, Liu D, Kundu RV. Perception of Skin Cancer Risk by Those with Ethnic Skin. Arch Dermatol 145;207-208, 2009. (PMID 19221276)
Kim N, Boone S, Ortiz S, Mallet K, Stapleton J, Turrisi R, Yoo S, West D, Radema,er A, Robinson JK. Squamous cell carcinoma in solid organ transplant recipients: Influences on perception of risk and optima l time to provide education. Arch Dermatol, 2009.
Fabi SG, Hill C, Witherspoon JN, Boone SE, Hill C, West DP. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: A case report and review of the literature. J Drugs Dermatol, 2009.
Joshi SS, Boone SL, Alam M, Yoo S, White L, Rademaker A, Helenowski I, West DP, Kundu RV. Effectiveness, Safety, and Effect on Quality of Life of Topical Salicylic Acid Peels for Treatment of Postinflammatory Hyperpigmentation in Dark Skin. Dermatol Surg 2009;35(4):638-644. (PMID 19400885)
Boone SL, Stapleton J, Turrisi R, Ortiz S, Robinson JK, Mallett KA. Thoroughness of skin examination by melanoma patients: Influence of age, sex and partner. Austral.J Dermatol 2009;50:190-194.
Borovicka JH, Thomas L, Prince C, Mehregan DR. Scarring Alopecia: Clinical and Pathologic Study of Fifty-Four African American Women, International Journal of Dermatology, 2009; 48:840-845.
Heath CR, Burk CJ, Lawley LP, Mancini AJ, Connelly EA. Severe combined immunodeficiency (SCID)-associated dyschromia with subsequent repigmentation: a report of two patients. Pediatric Dermatology, 26: 162-168, 2009. (PMID 19419463)
Newman M, Stotland M, Ellis J. The safety of nanosized particules in titanium dioxide and zinc oxide-based sunscreens. JAAD, 2009;61:685-92.
Carson KR, Focosi D, Richey EA, Major EO, class="apple-style-span"Petrini M, West DP, Bennett CL. Monoclonal antibody-associated progressive multifocal leukoencephalopathy (PML) among patients treated with natalizumab, rituximab, and efalizumab: A review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol, 2009.
Robinson JK, Ortiz S. Use of photographs illustrating ABCDE criteria in skin self-examination. Arch Dermatol. 2009 Mar;145(3):332-3. (PMID: 19289774)
Kinahan KE, Gandhi M, Lacouture ME, Eilers R Jr, Haryani A, Didwania A, Sharp LK. Dermatologic issues in adult survivors of childhood cancer. J Cancer Surviv. 2009 May 28. [Epub ahead of print]. (PMID: 19475513)
Newman MD, Lertsburapa T, Mirzabeigi M, Mafee M, Guitart J, Gerami P. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma. Mod Pathol. 2009 May 15. [Epub ahead of print]. (PMID: 19448594)
Gerami P, Rosen S, Kuzel T, Boone SL, Guitart J. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma. Arch Dermatol. 2008 Jun;144(6):738-46. (PMID: 18559762)
Konheim A, Brebach E, Samuel J, Mellott A, Gandhi M, Lacouture ME. Magnetic resonance imaging of paronychia induced by cetuximab. Clin Exp Dermatol. 2009 Apr 27. [Epub ahead of print]. (PMID: 19438534)
Rosenbaum SE, Wu S, Newman MA, West DP, Kuzel T, Lacouture ME. Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib. Support Care Cancer.2008 Jun;16(6):557-66. Epub 2008 Feb 15. (PMID: 18274784)
Gerami P, Wickless SC, Rosen S, Kuzel TM, Ciurea A, Havey J, Guitart J. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma. J Am Acad Dermatol. 2008 Aug;59(2):245-54. Epub 2008 May 16. (PMID: 18314434)
Robinson JK, Kim J, Rosenbaum S, Ortiz S. Indoor tanning knowledge, attitudes, and behavior among young adults from 1988-2007. Arch Dermatol. 2008 Apr;144(4):484-8. (PMID: 18427042)
Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, Gleason KJ, Barnato SE, Elverman KM, Courtney DM, McKoy JM, Edwards BJ, Tigue CC, Raisch DW, Yarnold PR, Dorr DA, Kuzel TM, Tallman MS, Trifilio SM, West DP, Lai SY, Henke M. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA. 2008 Feb 27;299(8):914-24. (PMID: 18314434)
Lacouture ME, West DP, Tigue CC, Knox K, Bennett CL. Adverse events alert: Cutaneous toxicities of targeted cancer therapies. Community Oncol. 2008; 5(7):413-14.
Rosenbaum SE, Wu S, Newman MA, West DP, Kuzel T, Lacouture ME. Dermatological reactions to multitargeted tyrosin kinase inhibitor sunitinib. Support Care Cancer. 2008 Jun; 16(6):557-66. Epub 2008 Feb 15. (PMID: 18274784)